NEW YORK, Feb 27 - Packard BioScience said Tuesday it completed the sale of its nuclear products division, Canberra Industries, to Cogema of France.

Cogema bought Canberra for $170 million. Packard of Meriden, Conn.,  has said it would use the proceeds of the sale for debt repayment, research and development, and general purposes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.